Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium oxybate for reducing alcohol consumption and maintaining abstinence in alcohol dependence
2019-001834-33Phase 3Active
- Sponsor
- Laboratorio Farmaceutico CT
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of sodium oxybate in alcohol dependence, sponsored by Laboratorio Farmaceutico CT. Primary endpoint: Reduction in heavy drinking days. Started Jul 2020; status: active.
02
Drugs
sodium oxybate
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2019-001834-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001834-33.